郑重声明:斯道资本从没有通过微信、APP、网站或任何其他渠道以斯道资本名义进行任何此类活动,也没有授权任何实体或个人以斯道资本名义进行任何此类活动。斯道资本进一步声明其从不对外集资或募资,也不直接或间接销售任何投资理财产品,更不接受个人投资。

OrigynMED raises Series B+ round
The multi-hundred millions yuan round was led by LAV, with participation from existing investors Eight Roads and Sequoia Capital China, etc.

As founding investor of OrigynMED, Eight Roads has focused on the women’s health area since 2008 and shares OrigynMED's vision of building a world-leading med tech platform company driven by indigenous innovation and cutting-edge technology.  

Founded in 2015, OriGynMED provides overall solutions and cost-effective innovative products for healthcare niches. The company plans to launch a first gynecology innovative medical device product portfolio in 2021, and initiate a national clinical medical education and training program centered on minimally invasive gynecological surgery.

分享